The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study

The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study

ObjectivesGiven the high occurrence of asymptomatic subsets, the true prevalence of SARS-CoV-2 infection in rheumatic patients is still underestimated. This study aims to evaluate the seroprevalence of SARS-CoV-2 antibodies in rheumatic musculoskeletal diseases (RMD) patients receiving immunomodulat...

Full description

Bibliographic Details
Main Authors: Ennio Giulio Favalli, Andrea Gobbini, Mauro Bombaci, Gabriella Maioli, Martina Biggioggero, Elisa Pesce, Andrea Favalli, Martina Martinovic, Tanya Fabbris, Edoardo Marchisio, Alessandra Bandera, Andrea Gori, Sergio Abrignani, Renata Grifantini, Roberto Caporali
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Medicine
Subjects:
seroprevalence
SARS-CoV-2
humoral response
rheumatic musculoskeletal diseases
disease-modifying anti-rheumatic drugs
risk of infection
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.850858/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.850858/full

Similar Items